188 related articles for article (PubMed ID: 25016066)
1. An evaluation of the Qiagen HPV sign for the detection and genotyping of cervical lesions and oropharyngeal squamous cell carcinomas.
Ward C; Pedraza J; Kavanagh K; Johannessen I; Cuschieri K
J Virol Methods; 2014 Oct; 207():128-32. PubMed ID: 25016066
[TBL] [Abstract][Full Text] [Related]
2. Comparison of HPV sign genotyping test with INNO-LiPA HPV genotyping extra assay on histologic and cytologic cervical specimens.
Barbieri D; Nocera M; Gallinella G; Gentilomi GA; Plazzi M; Costa S; Santini D; Venturoli S
Diagn Microbiol Infect Dis; 2012 Sep; 74(1):43-8. PubMed ID: 22717156
[TBL] [Abstract][Full Text] [Related]
3. The original SPF10 LiPA25 algorithm is more sensitive and suitable for epidemiologic HPV research than the SPF10 INNO-LiPA Extra.
Geraets DT; Struijk L; Kleter B; Molijn A; van Doorn LJ; Quint WG; Colau B
J Virol Methods; 2015 Apr; 215-216():22-9. PubMed ID: 25698462
[TBL] [Abstract][Full Text] [Related]
4. Comparison of analytical and clinical performances of the digene HC2 HPV DNA assay and the INNO-LiPA HPV genotyping assay for detecting high-risk HPV infection and cervical neoplasia among HIV-positive African women.
Ngou J; Gilham C; Omar T; Goumbri-Lompo O; Doutre S; Michelow P; Kelly H; Didelot MN; Chikandiwa A; Sawadogo B; Delany-Moretlwe S; Meda N; Costes V; Mayaud P; Segondy M
J Acquir Immune Defic Syndr; 2015 Feb; 68(2):162-8. PubMed ID: 25394189
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the AdvanSure HPV GenoBlot assay with the INNO-LiPA HPV genotyping assay for human papillomavirus genotyping.
Chung HS; Lee M
J Clin Virol; 2014 May; 60(1):34-8. PubMed ID: 24636736
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples.
Jentschke M; Soergel P; Hillemanns P
J Virol Methods; 2013 Oct; 193(1):131-4. PubMed ID: 23707925
[TBL] [Abstract][Full Text] [Related]
7. Comparison of INNO-LiPA genotyping extra and hybrid capture 2 assays for detection of carcinogenic human papillomavirus genotypes.
Barzon L; Militello V; Pagni S; Palù G
J Clin Virol; 2012 Nov; 55(3):256-61. PubMed ID: 22877561
[TBL] [Abstract][Full Text] [Related]
8. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the clinical performance of restriction fragment mass polymorphism (RFMP) and Roche linear array HPV test assays for HPV detection and genotyping.
Lee HP; Cho W; Bae JM; Shin JY; Shin SK; Hwang SY; Min KT; Kim SN; Lee SJ; Kim SO; Yoo WD; Hong SP
J Clin Virol; 2013 Jun; 57(2):130-5. PubMed ID: 23410688
[TBL] [Abstract][Full Text] [Related]
10. High-risk HPV detection and genotyping by APTIMA HPV using cervical samples.
Pyne MT; Hamula CL; Tardif K; Law C; Schlaberg R
J Virol Methods; 2015 Sep; 221():95-9. PubMed ID: 25956671
[TBL] [Abstract][Full Text] [Related]
11. Comparison of molecular methods for detection of HPV in oral and oropharyngeal squamous cell carcinoma.
Kingma DW; Allen RA; Caughron SK; Melby M; Moore WE; Gillies EM; Marlar RA; Dunn TS
Diagn Mol Pathol; 2010 Dec; 19(4):218-23. PubMed ID: 21051999
[TBL] [Abstract][Full Text] [Related]
12. Digene HPV Genotyping RH Test RUO: comparative evaluation with INNO-LiPA HPV Genotyping Extra Test for detection of 18 high-risk and probable high-risk human papillomavirus genotypes.
Seme K; Lepej SZ; Lunar MM; Iscić-Bes J; Planinić A; Kocjan BJ; Vince A; Poljak M
J Clin Virol; 2009 Oct; 46(2):176-9. PubMed ID: 19683958
[TBL] [Abstract][Full Text] [Related]
13. Targeted next generation sequencing panel for HPV genotyping in cervical cancer.
Lippert J; Bønløkke S; Utke A; Knudsen BR; Sorensen BS; Steiniche T; Stougaard M
Exp Mol Pathol; 2021 Feb; 118():104568. PubMed ID: 33171155
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus detection and genotyping, by HC2, full-spectrum HPV and molecular beacon real-time HPV assay in an Irish colposcopy clinic.
Keegan H; Pilkington L; McInerney J; Jeney C; Benczik M; Cleary S; von Bunau G; Turner M; D'Arcy T; O' Toole S; Pal-Szenthe B; Kaltenecker B; Mózes J; Kovács A; Solt A; Bolger N; O'Leary J; Martin C
J Virol Methods; 2014 Jun; 201():93-100. PubMed ID: 24583109
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening.
Burroni E; Bonanni P; Sani C; Lastrucci V; Carozzi F; ; Iossa A; Andersson KL; Brandigi L; Di Pierro C; Confortini M; Levi M; Boccalini S; Indiani L; Sala A; Tanini T; Bechini A; Azzari C
J Med Virol; 2015 Mar; 87(3):508-15. PubMed ID: 25418873
[TBL] [Abstract][Full Text] [Related]
16. Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.
Rao A; Sandri MT; Sideri M; Young S; Sharma A; Behrens C
J Clin Virol; 2013 Sep; 58(1):161-7. PubMed ID: 23895930
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the PapilloCheck® assay with the digene HC2 HPV DNA assay for the detection of 13 high-risk human papillomaviruses in cervical and anal scrapes.
Didelot MN; Boulle N; Damay A; Costes V; Segondy M
J Med Virol; 2011 Aug; 83(8):1377-82. PubMed ID: 21678441
[TBL] [Abstract][Full Text] [Related]
18. Performance evaluation of Anyplex™II HPV28 detection kit in a routine diagnostic setting: comparison with the HPV Sign® Genotyping Test.
Marcuccilli F; Farchi F; Mirandola W; Ciccozzi M; Paba P; Bonanno E; Perno CF; Ciotti M
J Virol Methods; 2015 Jun; 217():8-13. PubMed ID: 25724435
[TBL] [Abstract][Full Text] [Related]
19. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
Učakar V; Poljak M; Oštrbenk A; Klavs I
J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
[TBL] [Abstract][Full Text] [Related]
20. Comparison of SPF10 real-time PCR and conventional PCR in combination with the INNO-LiPA HPV Genotyping Extra assay for the detection and typing of human papillomavirus in cervical samples.
Micalessi MI; Boulet GA; Pillet S; Jacquet J; Pozzetto B; Bogers JJ; Bourlet T
J Virol Methods; 2013 Dec; 194(1-2):113-7. PubMed ID: 23978605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
